BioSpace News Archive

BioAge Labs, Inc., a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, announced the appointment of BJ Sullivan, Ph.D., as Chief Strategy Officer.

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, will present new data evaluating the use and potential of its methylation-based multi-cancer early detection (MCED) platform at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 2-6.

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing and precision medicine, announced the availability of a Neuromuscular Disorders Panel.

Foundation for Sarcoidosis Research is proud to announce the release of the Ignore No More Campaign on Clinical Trials Diversity:Advancing Clinical Trial Equity for Black Patients with Sarcoidosis White Paper which summarizes the findings and recommendations from an IRB-approved national survey of Black Americans to get a better understanding of the challenges and experiences they face in considering and participating in clinical trials.

The Insight Partners published latest research report on “Influenza Vaccines Market Size Report, Share, Trends, Growth, Demand & Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group”, the global market size is projected to reach USD 12,272.49 million by 2028 from USD 7,478.53 million in 2021

Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen technology as part of the diagnostic process to monitor a patient with a history of Chronic Myeloid Leukemia and p210 isoform expression which allowed the lab to uncover an additional oncogene isoform expression.

Inversago Pharma Inc. (“Inversago”) today announced positive results from a proof-of-concept study of INV-202 in a mouse model of obese asthma at the American Thoracic Society (ATS) International Conference taking place from May 19-24, 2023, in Washington, D.C.

Tevogen Bio is pleased to announce that it will present the proof-of-concept clinical trial results of TVGN 489, the company’s first clinical product from its ExacTcell platform, at the 5th Annual Allogeneic Therapies Summit in Boston, MA.

IceCure Medical Ltd. today reported financial results as of and for the three months ended March 31, 2023 as well as operational and recent corporate developments.

Thermo Fisher Scientific to Present at Bernstein 39th Annual Strategic Decisions Conference on May 31st , 2023.